From bench to bedside and back: prognostic groups of Phase 2 study of second-line FOLFIRI-aflibercept in prospectively stratified, RAS wild type, anti-EGFR resistant, metastatic colorectal cancer patients: The DISTINCTIVE trial—A GISCAD study

Lai, Eleonora ; Murgioni, Sabina ; Ziranu, Pina ; Aprile, Giuseppe ; Zaniboni, Alberto ; Pretta, Andrea ; Nappo, Floriana ; Mosconi, Stefania ; Bittoni, Alessandro ; Squadroni, Michela ; Cappetta, Alessandro ; Daniel, Francesca ; Mascia, Luigi ; Rosati, Gerardo ; Zampino, M. Giulia ; Gelsomino, Fabio ; Simionato, Francesca ; Rofei, Michela ; Pella, Nicoletta ; Scartozzi, Mario

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15571-e15571 [Periódico revisado por pares]

Texto completo disponível